A detailed history of Wetzel Investment Advisors, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 64 shares of OGN stock, worth $1,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64
Previous 64 -0.0%
Holding current value
$1,312
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$13.78 - $18.8 $689 - $940
50 Added 357.14%
64 $1,000
Q4 2023

Jan 31, 2024

BUY
$10.95 - $17.32 $153 - $242
14 New
14 $0

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.21B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Wetzel Investment Advisors, Inc. Portfolio

Follow Wetzel Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetzel Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wetzel Investment Advisors, Inc. with notifications on news.